ebola virus

5 FDA approval decisions to watch in the 4th quarter
5 FDA approval decisions to watch in the 4th quarter
BioPharma Dive
FDA
drug approvals
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Regeneron
EB3
ebola virus
Alkermes
ALKS-3831
schizophrenia
bipolar disorder
Bristol-Myers Squibb
liso-cel
non-Hodgkin lymphoma
roxadustat
FibroGen
chronic kidney disease
Flag link:
J&J’s Ebola vaccine approved in EU
J&J’s Ebola vaccine approved in EU
Pharmaforum
Europe
JNJ
ebola virus
Janssen
vaccines
Bavarian Nordic
Flag link:
Merck's Ebola Vaccine Approved for Use in Four African Countries
Merck's Ebola Vaccine Approved for Use in Four African Countries
Motley Fool
Merck
Africa
vaccines
Ervebo
ebola virus
Congo
Ghana
Zambia
Burundi
Flag link:
‘Against all odds’: The inside story of how scientists across three continents produced an Ebola vaccine
‘Against all odds’: The inside story of how scientists across three continents produced an Ebola vaccine
Stat
ebola virus
vaccines
WHO
Merck
Flag link:
Following Merck approval, Gavi authorizes $178M to build Ebola vaccine stockpile
Following Merck approval, Gavi authorizes $178M to build Ebola vaccine stockpile
Fierce Pharma
Merck
vaccines
ebola virus
Ervebo
GAVI
Flag link:
The Ebola Vaccine Is Now Officially Here With Approval In Europe
The Ebola Vaccine Is Now Officially Here With Approval In Europe
Forbes
Europe
ebola virus
vaccines
Merck
Ervebo
Flag link:
J&J's Experimental Ebola Vaccine to be Deployed in the Congo to Help Stem Outbreak
J&J's Experimental Ebola Vaccine to be Deployed in the Congo to Help Stem Outbreak
BioSpace
JNJ
Congo
vaccines
WHO
ebola virus
Flag link:
CHMP backs world’s first Ebola vaccine from Merck, NewLink
CHMP backs world’s first Ebola vaccine from Merck, NewLink
Pharmaforum
Merck
ebola virus
vaccines
CHMP
EMA
Europe
NewLink Genetics
Flag link:
Congo to start using J&J Ebola vaccine in November
Congo to start using J&J Ebola vaccine in November
Yahoo/Reuters
Congo
JNJ
ebola virus
vaccines
Flag link:
Merck's Ebola vaccine tees up FDA date, aiming for first status
Merck's Ebola vaccine tees up FDA date, aiming for first status
Fierce Biotech
Merck
ebola virus
vaccines
FDA
V920
Flag link:
HHS pledges $23M to develop Merck's experimental Ebola vaccine
HHS pledges $23M to develop Merck's experimental Ebola vaccine
Beckers Hospital Review
HHS
vaccines
Merck
V920
ebola virus
Flag link:
Deploying Experimental Vaccines Against Ebola
Deploying Experimental Vaccines Against Ebola
Forbes
JNJ
vaccines
ebola virus
Merck
WHO
Flag link:
GSK offloads Ebola vaccines as testing of J&J shot ramps up
GSK offloads Ebola vaccines as testing of J&J shot ramps up
Fierce Biotech
GSK
ebola virus
JNJ
vaccines
Sabin Vaccine Institute
Flag link:
Two Experimental Drugs Show Promise in Inhibiting Ebola Virus
Two Experimental Drugs Show Promise in Inhibiting Ebola Virus
BioSpace
CDC
ebola virus
Gilead Sciences
remdesivir
Mapp Biopharmaceutical
ZMapp
Flag link:
The data are clear: Ebola vaccine shows ‘very impressive’ performance in outbreak
The data are clear: Ebola vaccine shows ‘very impressive’ performance in outbreak
Stat
vaccines
ebola virus
Merck
Flag link:
Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year
Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year
Fierce Pharma
Merck
vaccines
Congo
ebola virus
Flag link:
A pivotal day in world’s response to Ebola nears: the launch of a clinical trial
A pivotal day in world’s response to Ebola nears: the launch of a clinical trial
Stat
ebola virus
clinical trials
Congo
Flag link:
Merck’s Experimental Ebola Vaccine Seeing Wide Use in Outbreak
Merck’s Experimental Ebola Vaccine Seeing Wide Use in Outbreak
Bloomberg
Merck
vaccines
ebola virus
Flag link:
Big Pharma Rises To The Ebola Challenge
Big Pharma Rises To The Ebola Challenge
Forbes
ebola virus
vaccines
Flag link:
BIO18: Merck's Ebola lessons, New Jersey vies for biotech jobs
BIO18: Merck's Ebola lessons, New Jersey vies for biotech jobs
Biopharma Dive
Merck
ebola virus
New Jersey
biotech
BIO 2018
Flag link:

Pages